Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets
about
Development of manganese-based nanoparticles as contrast probes for magnetic resonance imagingMetal-organic frameworks as biosensors for luminescence-based detection and imagingVision 20/20: Single photon counting x-ray detectors in medical imagingMagnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyMolecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsAssessing the barriers to image-guided drug delivery.Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombusManganese-based MRI contrast agents: past, present and future.Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranosticsEmerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Plasmonic nanobubbles as tunable cellular probes for cancer theranosticsNanomedicine strategies for molecular targets with MRI and optical imaging.Polymer beacons for luminescence and magnetic resonance imaging of DNA deliveryDesign of Hydrated Porphyrin-Phospholipid Bilayers with Enhanced Magnetic Resonance Contrast.Bioresponsive, cell-penetrating, and multimeric MR contrast agents.A molecularly targeted theranostic probe for ovarian cancer.A Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.Multifunctional Magnetic Nanoparticles for Medical Imaging Applications.Human ferritin cages for imaging vascular macrophagesMolecular MRI of Thrombosis.Aptamer-conjugated multifunctional nanoflowers as a platform for targeting, capture, and detection in laser desorption ionization mass spectrometry.Revisiting an old friend: manganese-based MRI contrast agentsSynergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.Discrete bimodal probes for thrombus imaging.Fibrin-targeted PET probes for the detection of thrombi.pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.Optical imaging of fibrin deposition to elucidate participation of mast cells in foreign body responses.Polydisulfide manganese(II) complexes as non-gadolinium biodegradable macromolecular MRI contrast agents.Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Interventional oncology: the future.Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come?Nanotechnology applications for glioblastoma.Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential.Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.Lipophilic silver nanoparticles and their polymeric entrapment into targeted-PEG-based micelles for the treatment of glioblastoma.Theranostic magnetic core-plasmonic shell star shape nanoparticle for the isolation of targeted rare tumor cells from whole blood, fluorescence imaging, and photothermal destruction of cancer.
P2860
Q22064299-EC90B311-ADC8-4408-B500-69395F1D5911Q26738632-3BBC656F-46C9-4EE6-A510-1F5A09EDF9ECQ26824226-3622D51D-B69B-49D7-B84A-7473322778CAQ27004205-5E972BB1-AA14-40E2-858D-A710C6F4CB7CQ27027613-6B09849D-978D-4738-B90D-6477CEB1D8B7Q28304646-90CA5038-2919-405B-93D7-1F5F9DD698EEQ30422169-3BD06ECD-1641-4129-B4EB-0A17A88F8F51Q30448359-FE98FDCF-14C5-4101-B876-CA2BB804862BQ30461349-0B0BA431-D6B6-4688-96AC-2BBA5D45F2A6Q30462417-32C8911F-F549-4E94-9294-DE0C44200303Q30475719-AC995E6B-1070-4789-B08E-DF0309C55B27Q30476207-8851E86C-20CC-4329-B74D-DDC5539266B3Q30481471-4DB96A2A-0476-43F0-B5C7-8FC317107828Q30490915-228A7ECC-E283-4633-BA3F-93623B4B5B1DQ31136575-046D1720-6359-4186-AE97-5B50F646E096Q33470566-4F890EAD-85DA-4654-BA3F-E91016ADBC1DQ33550025-16C28BB1-083F-42BD-ADFF-8CBFA836F11CQ33812462-FF4F0BF2-53D0-475C-9786-30C94B6A23F0Q33946006-4BA90DA4-B21E-4204-80D6-EBF9D6251F18Q34452433-2741D749-B838-4F29-90CD-71BB101438CBQ34497634-AA84FD2C-A29E-4684-971B-BC156C4E0E34Q34501226-CE2A52B0-A9DD-4EB4-A8A5-B970D7E87F98Q35169228-D13B83E8-0C64-4EF7-8FF4-04382328EFB5Q35317271-F3BBB9DD-D0B4-4D0D-805A-DE39FACA7F92Q36095999-DC81814A-E83A-43AF-AE38-D2A91E06EAAEQ36673486-1CBC6794-F171-4D9A-876A-7CCBDD09B90AQ37592063-4190D05C-AE36-4981-810E-BA85F8D63AE5Q37602786-58319FB2-4987-451A-BA17-256DC813B066Q37609165-08AD6764-3598-4758-904E-05FB0A3C456AQ37631874-916B15F3-3383-4B0B-BF4D-E1F45BD4EFCAQ37869421-C068392C-8AB4-44CA-906C-E75BA1E6FD51Q37957956-0BF9EBF0-FFE8-4F68-A386-B2EAB55462F3Q37978315-53B3A19B-D023-4DB6-BD91-EFF112D71134Q38020195-9DF64688-17F6-4E9B-9A3D-A1309FD2D048Q38022853-8801A461-66FC-42BE-9DAE-03CD48A059E5Q38334528-10E99C9B-E968-4FEE-B2FD-E8DE84D57D68Q38707035-DF060129-D53F-4255-A912-0EB49CBFFE5DQ38876475-F3601B61-0458-43C5-8B0D-76A65E8B15A8Q39237779-D4466B6A-3706-44DD-ABB6-D468AD775BABQ39251454-53DD80F0-10EA-4E16-B447-4FD815981706
P2860
Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Ligand-directed nanobialys as ...... ce imaging of vascular targets
@en
type
label
Ligand-directed nanobialys as ...... ce imaging of vascular targets
@en
prefLabel
Ligand-directed nanobialys as ...... ce imaging of vascular targets
@en
P2093
P2860
P356
P1476
Ligand-directed nanobialys as ...... ce imaging of vascular targets
@en
P2093
Angana Senpan
Gregory M Lanza
Mike J Scott
Patrick J Gaffney
Samuel A Wickline
Shelton D Caruthers
P2860
P304
P356
10.1021/JA801482D
P407
P50
P577
2008-06-24T00:00:00Z